289 related articles for article (PubMed ID: 27001376)
1. INTEGRATING HEALTH TECHNOLOGY ASSESSMENT PRINCIPLES IN FORMULARY MANAGEMENT.
Teng M; Khoo AL; Zhao YJ; Lin L; Lim BP
Int J Technol Assess Health Care; 2016 Jan; 32(1-2):81-7. PubMed ID: 27001376
[TBL] [Abstract][Full Text] [Related]
2. The formulary decision-making process in a US academic medical centre.
Nash DB; Catalano ML; Wordell CJ
Pharmacoeconomics; 1993 Jan; 3(1):22-35. PubMed ID: 10146985
[TBL] [Abstract][Full Text] [Related]
3. Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions.
Wong CKH; Wu O; Cheung BMY
Appl Health Econ Health Policy; 2018 Feb; 16(1):5-14. PubMed ID: 28702874
[TBL] [Abstract][Full Text] [Related]
4. Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications.
Matlala M; Gous AG; Godman B; Meyer JC
Expert Rev Clin Pharmacol; 2017 Nov; 10(11):1273-1280. PubMed ID: 28776442
[TBL] [Abstract][Full Text] [Related]
5. Pharmacoeconomics and formulary decision making.
Sanchez LA
Pharmacoeconomics; 1996; 9 Suppl 1():16-25. PubMed ID: 10160112
[TBL] [Abstract][Full Text] [Related]
6. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
[TBL] [Abstract][Full Text] [Related]
7. Formulary management in the Department of Defense.
Trice S; Devine J; Mistry H; Moore E; Linton A
J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127
[TBL] [Abstract][Full Text] [Related]
8. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
Weekes LM; Day RO
Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
[TBL] [Abstract][Full Text] [Related]
9. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
[TBL] [Abstract][Full Text] [Related]
10. Use of pharmacoeconomic data in making hospital formulary decisions.
Odedina FT; Sullivan J; Nash R; Clemmons CD
Am J Health Syst Pharm; 2002 Aug; 59(15):1441-4. PubMed ID: 12166044
[TBL] [Abstract][Full Text] [Related]
11. Formulary decision making: identifying factors that influence P&T committee drug evaluations.
Segal R; Pathak DS
Hosp Formul; 1988 Feb; 23(2):174-8. PubMed ID: 10286022
[TBL] [Abstract][Full Text] [Related]
12. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
[TBL] [Abstract][Full Text] [Related]
13. A survey of Pharmacy and Therapeutic committees across Canada: scope and responsibilities.
Mittmann N; Knowles S
Can J Clin Pharmacol; 2009; 16(1):e171-7. PubMed ID: 19242000
[TBL] [Abstract][Full Text] [Related]
14. How to use structured decision making in developing therapeutic, cost-effective formulary systems.
Crane VS
Hosp Formul; 1993 Oct; 28(10):859-62, 865-7. PubMed ID: 10129135
[TBL] [Abstract][Full Text] [Related]
15. Technology assessment and the drug use process.
Solomon DK; Gourley DR; Brown JR; Gourley GA; Humma LM
Am J Manag Care; 1999 Feb; 5(2):220-9; quiz 230-2. PubMed ID: 10346517
[TBL] [Abstract][Full Text] [Related]
16. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
[TBL] [Abstract][Full Text] [Related]
17. Tri-hospital formulary management: a joint effort to standardize therapy and reduce costs.
Kile DM; McGrath ME; Schindel LP
Hosp Formul; 1987 Feb; 22(2):176, 178, 181. PubMed ID: 10280289
[TBL] [Abstract][Full Text] [Related]
18. Developing an effective P & T Committee, Part 2.
Abramowitz PW; Godwin HN; Latiolais CJ; McDougal TR; Miller WA; Ravin RL
Hosp Formul; 1985 Oct; 20(10):1071-2, 1078-81, 1086 passim. PubMed ID: 10273830
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoeconomic analysis in formulary decisions: an international perspective.
Johnson JA; Bootman JL
Am J Hosp Pharm; 1994 Oct; 51(20):2593-8. PubMed ID: 7847423
[TBL] [Abstract][Full Text] [Related]
20. Development and implementation of a comprehensive, criteria-based drug-use review program.
Todd MW; Keith TD; Foster MT
Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
